PGR and ovarian carcinoma: Inhibitory effects of high dose MPA (10 μM) have been noted before in ovarian cancer cells (SKOV3 and OVCAR3)52,53 and could be either caused by direct cytotoxicity or decreased proliferation via the progesterone receptor and lower gonadotropin and estrogen levels54.